Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy

L Morató1,2,3, M Ruiz1,2,3, J Boada4

  • 1Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

Insights

Restoring sirtuin 1 (SIRT1) function in X-linked adrenoleukodystrophy (X-ALD) mice normalized mitochondrial function and reversed axonal degeneration. This suggests SIRT1 reactivation is a promising therapeutic strategy for X-ALD and similar conditions.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Genetics

Background:

  • Oxidative stress and mitochondrial dysfunction are key drivers of axonal degeneration in neurological disorders.
  • X-linked adrenoleukodystrophy (X-ALD), a peroxisomal disease, is characterized by impaired axonal integrity.
  • Sirtuin 1 (SIRT1), a crucial regulator of mitochondrial health, is found to be deficient in X-ALD.

Purpose of the Study:

  • To investigate the role of SIRT1 in X-ALD pathogenesis.
  • To evaluate the therapeutic potential of restoring SIRT1 activity in a mouse model of X-ALD.

Main Methods:

  • Utilized a mouse model of X-linked adrenoleukodystrophy (X-ALD).
  • Employed resveratrol treatment and transgenic overexpression to enhance SIRT1 activity.
  • Assessed redox homeostasis, mitochondrial respiration, and bioenergetic parameters.
  • Evaluated axonal degeneration and locomotor function.

Main Results:

  • Both resveratrol treatment and SIRT1 overexpression restored normal redox balance and mitochondrial respiration in X-ALD mice.
  • These interventions successfully reversed axonal degeneration and improved associated motor deficits.
  • The study confirmed impaired SIRT1 activity in the X-ALD model.

Conclusions:

  • Reactivation of SIRT1 is a viable therapeutic approach for X-ALD.
  • Targeting SIRT1 may offer a strategy for treating axonopathies with impaired redox and energy homeostasis.
  • Restoring mitochondrial function via SIRT1 is crucial for preventing axonal degeneration.

Related Concept Videos

Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.7K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
22.3K